Improving Outcomes in Peripheral Bypass: The role of TTFM and HFUS

UPDATED INFO!

‍

Join our live customer webinar on June 18th, 2025 at 15:00 - 16:00 (CEST) / 09:00 - 10:00 (EDT)‍

Up to 20% of peripheral bypasses fail without a clear cause within the first year, and there's still no standard for completion control. While some hospitals use TTFM and HFUS routinely, there are more clinical questions to be addressed.

Join us in hearing from the lead investigator of the newly started international PATENT study, which was designed to establish evidence-based recommendations and reduce graft failure in CLTI patients. You'll also gain real-world insights from experienced vascular surgeons using Medistim technology to improve outcomes in daily practice.

Hear from:

• VP Medical Medistim Anne Waaler giving background of the PATENT study
• Professor, MD. Michael Conte, UCSF University of California, on open surgery and the value of flow and imaging
• MD. Katariina Noronen, Helsinki University Central Hospital HUCH shares case experience with TTFM and HFUS
• Dr. Cecilia Fenelli, Azienda USL Toscana Centro, Florence

Agenda:

• PATENT study by Anne Waaler, Medistim
• Interview with Dr. Michael Conte
• Experience with TTFM & HFUS at Helsinki University Hospital by Dr. Katariina Noronen
• Case study by Dr. Cecilia Fenelli, Azienda USL Toscana Centro, Florence
• Live Q&A at the end

‍

Don’t miss this opportunity to gain actionable knowledge and connect with peers in the vascular surgery community.

‍